Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
20.35
-0.65 (-3.09%)
Dec 3, 2024, 1:44 PM EST - Market open
Viridian Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 0.3 | 0.31 | 1.77 | 2.96 | 1.05 | 4.46 | Upgrade
|
| Revenue Growth (YoY) | -12.97% | -82.28% | -40.20% | 182.19% | -76.46% | -46.80% | Upgrade
|
| Cost of Revenue | 159.77 | 159.77 | 100.89 | 56.89 | 28.3 | 32.79 | Upgrade
|
| Gross Profit | -159.46 | -159.45 | -99.12 | -53.92 | -27.25 | -28.33 | Upgrade
|
| Selling, General & Admin | 78.49 | 95 | 35.18 | 25.81 | 13.27 | 11.65 | Upgrade
|
| Operating Expenses | 123.58 | 95 | 35.18 | 25.81 | 13.27 | 11.65 | Upgrade
|
| Operating Income | -283.04 | -254.45 | -134.3 | -79.73 | -40.52 | -39.98 | Upgrade
|
| Interest Expense | -2.75 | -1.85 | -0.49 | -0 | -0.51 | -0.84 | Upgrade
|
| Interest & Investment Income | 28.86 | 18.56 | 4.92 | 0.32 | 0.17 | 0.94 | Upgrade
|
| EBT Excluding Unusual Items | -257.02 | -237.73 | -129.87 | -79.41 | -40.85 | -39.87 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | - | -2 | Upgrade
|
| Other Unusual Items | 0.18 | - | - | - | - | - | Upgrade
|
| Pretax Income | -257.08 | -237.73 | -129.87 | -79.41 | -110.72 | -41.87 | Upgrade
|
| Net Income | -257.08 | -237.73 | -129.87 | -79.41 | -110.72 | -41.87 | Upgrade
|
| Net Income to Common | -257.08 | -237.73 | -129.87 | -79.41 | -110.72 | -41.87 | Upgrade
|
| Shares Outstanding (Basic) | 60 | 45 | 32 | 12 | 4 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 60 | 45 | 32 | 12 | 4 | 2 | Upgrade
|
| Shares Change (YoY) | 42.07% | 39.48% | 169.22% | 235.07% | 70.27% | 5.87% | Upgrade
|
| EPS (Basic) | -4.26 | -5.31 | -4.05 | -6.66 | -31.13 | -20.04 | Upgrade
|
| EPS (Diluted) | -4.26 | -5.31 | -4.05 | -6.66 | -31.13 | -20.04 | Upgrade
|
| Free Cash Flow | -197.43 | -185.07 | -94.64 | -54.92 | -29.82 | -36.14 | Upgrade
|
| Free Cash Flow Per Share | -3.27 | -4.14 | -2.95 | -4.61 | -8.38 | -17.30 | Upgrade
|
| Operating Margin | -93722.19% | -81035.03% | -7579.23% | -2690.79% | -3858.95% | -896.19% | Upgrade
|
| Profit Margin | -85127.15% | -75711.46% | -7329.23% | -2680.16% | -10544.29% | -938.65% | Upgrade
|
| Free Cash Flow Margin | -65374.83% | -58938.85% | -5340.58% | -1853.49% | -2840.10% | -810.13% | Upgrade
|
| EBITDA | -282.47 | -253.93 | -134.05 | -79.61 | -40.28 | -39.69 | Upgrade
|
| D&A For EBITDA | 0.57 | 0.52 | 0.26 | 0.12 | 0.24 | 0.29 | Upgrade
|
| EBIT | -283.04 | -254.45 | -134.3 | -79.73 | -40.52 | -39.98 | Upgrade
|
| Revenue as Reported | - | - | - | - | 1.05 | 4.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.